Profusa, Inc. Common Stock (PFSA) Stock
Key stats
- Market cap
- $333,105.85
- EPS (TTM)
- $867.20
- Volume
- Loading
- 52-week high
- $28.32
- 52-week low
- $0.05
Source: third-party data provider, as of November 13, 2026
Compare with PFSA
Technical indicators
- RSI 14
- 34.03
- MACD 12/26/9
- -0.35
- EMA 9 of MACD
- -0.42
- MACD histogram
- 0.06
- SMA 50
- $1.51
- Price below SMA 50
- EMA 50
- $2.91
- Price below EMA 50
- SMA 200
- $63.28
- Price below SMA 200
- EMA 200
- $188.13
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
About Profusa, Inc. Common Stock
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jack E. Stover CPA | CEO & Executive Chairman | 1953 |
| Mr. Fred S. Knechtel | Chief Financial Officer | 1961 |
| Dr. Chung-Bin Hwang Ph.D. | President | 1968 |
| Mr. William McMillan | Co-founder, Chief Scientific Officer & Head of Research | 1951 |
| Mr. David Icke | Head of Digital Health Business | — |
| Mr. Sean Givens | Head of Government Business | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 34.03
- MACD 12/26/9
- -0.35
- EMA 9 of MACD
- -0.42
- MACD histogram
- 0.06
- SMA 50
- $1.51
- Price below SMA 50
- EMA 50
- $2.91
- Price below EMA 50
- SMA 200
- $63.28
- Price below SMA 200
- EMA 200
- $188.13
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -65.3 | -30.1 | -21.4 | -22.4 | -11.0 | -34.2 | ||||||
| 2026 | -7.3 | -84.4 | -48.1 | +3.0 | -36.9 | -66.0 | -67.4 | -22.1 | -31.3 | -62.6 | -15.4 |
Corporate actions
Upcoming
No upcoming corporate actions for PFSA




